Tag:
Foundation Medicine
Latest Headlines
Latest Headlines
Kleiner Perkins to back early-stage biotechs with $525M fund
Kleiner Perkins Caulfield & Byers has closed the books on a new $525 million fund. And a chunk of that treasure is earmarked for early-stage life science companies.
Gene study finds tumor-cell flaw possibly vulnerable to Pfizer, AZ cancer meds
More evidence that drugs and diagnostics will be playing together often: Researchers sequencing genes in colon and lung tumors found mutations that could be targeted with existing drugs. The study
DNA sequencing exposes new uses for Pfizer targeted cancer drugs
As pharma companies expand their use of DNA sequencing for drug R&D, researchers have uncovered some potential new targets for existing cancer drugs that are likely to spur further use of
Google Ventures, VCs backing tech focused on genomics
In its examination of the many potential challenges in genomics, Bloomberg made note of how venture capital is playing a role in advancing technologies that aim to tap the full potential of genomic...
J&J links up with Foundation Medicine for cancer genomic test
Foundation Medicine, a provider of cancer genomic tests and online test data access, has inked a collaboration pact with Johnson & Johnson's ( $JNJ ) pharma R&D unit to find biomarkers with...
Foundation Medicine to collaborate with J&J unit
Foundation Medicine is back in the news this week, inking a deal to collaborate with Johnson & Johnson Pharmaceutical Research and Development. The partners will use Foundation's cancer genomic
Foundation Medicine raises $33.5M in expanded Series A
Cambridge, MA-based cancer diagnostics firm Foundation Medicine has closed an expanded Series A financing, bringing the total raised in the round to $33.5 million. Investors included Third Rock
Google, Kleiner Perkins boost sequencing startup's A round to $33.5M
A pair of high-profile venture investors has joined forces to finance a startup sequencing outfit that has some ambitious near-term marketing plans to start selling a test that can help match cancer
Cambridge startup lands $25M round for genetic sequencing play
Cambridge, MA-based Foundation Medicine has raised $25 million in a Series A, coming out of stealth mode with bold plans to create clinical lab tests that can use the latest in genetic sequencing
Ex-CombinatoRx CEO gets back to start-up mode
Alexis Borisy, who bounced out of the CEO's office at CombinatoRx last summer after a lead program foundered, has taken up a role at Third Rock Ventures . And Xconomy reports that he's also helming a
